|
|
Article: New drug helps relieve chemotherapy-related symptoms. (Updates).(Brief Article)
- Article from:
- FDA Consumer
- Article date:
- July 1, 2003
CopyrightCOPYRIGHT 2003 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Chemotherapy is often distressing for cancer patients due to the debilitating nausea and vomiting associated with the treatment. The symptoms can even cause patients to refuse further chemotherapy treatments. A new drug, recently approved by the FDA, can help prevent these symptoms when used in combination with other anti-nausea and anti-vomiting drugs.
Emend (aprepitant) is the first approved therapy that prevents the nausea and vomiting that many patients experience more than 24 hours after receiving chemotherapy.
Emend is given along with two other drugs for three days, starting ...